SUBSCRIBE
SUBSCRIBE

Preclinical

Keitma/Shutterstock
Business
Sanofi Keeps on Rolling With Biond Biologics Partnership
The novel immune checkpoint inhibitor Sanofi deemed worthy of such an investment is BND-22, a humanized IgG4 antagonist antibody targeting the Ig-like transcript 2 (ILT2) receptor, an inhibitory receptor expressed on both innate and adaptive immune cells.
January 12, 2021
 · 
3 min read
 · 
Heather McKenzie
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 12, 2021.
January 12, 2021
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
2021 Biopharma Update on the Novel Coronavirus: January 5
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for January 5, 2021.
January 4, 2021
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
December 22, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: December 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 22, 2020.
December 22, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 15
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 15, 2020.
December 15, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Photo Courtesy of Faze Medicines
Business
Biomolecular Condensates Gain More Funding as Faze Snags $81M for ALS & DM1
Cambridge-based Faze Medicines, the biotechnology company that develops therapeutics based on biomolecular condensates, announced today that it has raised $81 million in a Series A round of financing.
December 10, 2020
 · 
3 min read
 · 
Krystle Vermes
Policy
Biopharma Update on the Novel Coronavirus: December 8
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 8, 2020.
December 7, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: December 1
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 1, 2020.
December 1, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: November 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
November 23, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Drug Development
Gyros Protein Technologies Introduces Gyrolab Generic Rodent ADA Kit Reagents to Support Preclinical Immunogenicity Assessment
May 2, 2024
 · 
2 min read
Drug Development
SCYNEXIS Presented Preclinical Data on Second Generation Fungerp SCY-247 at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global, Formerly ECCMID)
April 30, 2024
 · 
7 min read
Drug Development
InFlectis BioScience awarded $650K grant from the National Multiple Sclerosis Society to advance IFB-048 preclinical development in Multiple Sclerosis; Research to be Performed by Prof. Popko of Northwestern University
April 30, 2024
 · 
2 min read
Drug Development
Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)
April 30, 2024
 · 
8 min read
Drug Development
HanxBio announces the publication of a research paper in Scientific Reports on preclinical evaluation of Narazaciclib for the treatment of acute myeloid leukemia (AML)
April 23, 2024
 · 
2 min read
Drug Development
AAVantgarde presents positive preclinical data in large animal models from its Stargardt disease program in an oral presentation at the ASGCT 2024 annual meeting
April 23, 2024
 · 
2 min read
Drug Development
PharmAbcine’s U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
April 22, 2024
 · 
5 min read
Drug Development
Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
April 22, 2024
 · 
8 min read
Drug Development
Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting
April 22, 2024
 · 
4 min read
Drug Development
Affinia Therapeutics to Present Data on Novel Cardiotropic and BBB-Penetrant AAV Capsids and Preclinical Efficacy and Safety in Genetic Cardiomyopathies and Sporadic ALS at the American Society of Gene & Cell Therapy 2024 Annual Meeting
April 22, 2024
 · 
5 min read
Drug Development
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
April 22, 2024
 · 
6 min read
Drug Development
Salubris Biotherapeutics Announces $35 Million in Financing and Provides Pipeline Progress Update
April 22, 2024
 · 
6 min read
Drug Development
Hyundai Bioscience announces its successful result from a preclinical study of a Niclosamide-based oral anticancer drug to treat triple-negative breast cancer
April 22, 2024
 · 
4 min read
Business
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
April 18, 2024
 · 
4 min read
Drug Development
Cantargia Publishes New Data on the CAN10 Antibody, Detailing its Interaction with IL1RAP and Functional Inhibition
April 17, 2024
 · 
4 min read
Drug Development
Derm-Biome Pharmaceuticals’ topical therapy shows positive results in preclinical skin cancer trial: drug prevents the development of precancerous skin conditions and treats existing skin cancers with no observable side effects.
April 17, 2024
 · 
2 min read
Drug Development
Pantheon Vision Announces Two Successful Pre-Submission Meetings With the FDA
April 17, 2024
 · 
1 min read
Drug Development
Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting
April 16, 2024
 · 
7 min read
Drug Development
Jaya Biosciences Presents Updated Preclinical Data in Alzheimer’s Disease at the 45th SIMD Annual Meeting
April 16, 2024
 · 
6 min read
Drug Development
Nutcracker Therapeutics Demonstrates Enhanced Functional Activity of Prostate Cancer Candidate NTX-470 at the 2024 AACR Annual Meeting
April 11, 2024
 · 
4 min read
Load More